 |
|
|
| |
 |
Professor J.R.T. Monson
21-08-2008
Despite the lack of international data demonstrating its benefits, colorectal cancer screening does improve mortality, says Professor J.R.T Monson of the University of Hull, UK.
» Read more...
|
|
| |
 |
Professor Bogda Koczwara
15-07-2008
Issues of sexuality and fertility are as important as the cancer, particularly in women diagnosed with breast cancer, says a medical oncologist.
» Read more...
|
|
| |
 |
Professor Dr. Mark Pegram
8-07-2008
The positive diagnosis of HER-2 breast cancer should be confirmed by a central reference laboratory due to the high number of falsepositives in community testing,
says a US researcher.
» Read more...
|
|
| |
 |
Professor Joseph James McKendrick
1-07-2008
Older patients with colorectal cancer (CRC) should be afforded equal access to adjuvant therapy as their younger counterparts because of the comparable treatment benefits and acceptable toxicity levels, says a leading oncologist.
» Read more...
|
|
| |
 |
Professor Sunil Lakhani
24-06-2008
Making absolute assumptions based on molecular classification of breast cancer will not help patient management, says an eminent molecular pathologist.
» Read more...
|
|
| |
 |
Professor Ian Olver
17-06-2008
Excerpts of the plenary lecture at the 1st KL International Breast and Colorectal Cancer Congress, 9-11 August, KL, by Professor Ian Olver, clinical director of the Royal Adelaide Hospital Cancer Centre and clinical professor in the department of medicine, University of Sydney, Australia.
» Read more...
|
|
| |
 |
Professor Dr. Martine Piccart-Gebhart
13-06-2008
Trastuzumab use dependent on risks
Selection of a trastuzumab treatment regimen depends on whether there is more worry about the risk of cardiac failure or an early relapse, says an eminent oncologist.
» Read more...
|
|
|
| |
| |
9 article(s) found |
Displaying article 1 - 8 |
Page 1 of 2 |
|
| [1] 2 » |
| |
|
|
|
